Biosyent (Biosyent) COGS-to-Revenue : 0.19 (As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Biosyent COGS-to-Revenue?

Biosyent's Cost of Goods Sold for the three months ended in Dec. 2023 was $1.17 Mil. Its Revenue for the three months ended in Dec. 2023 was $6.17 Mil.

Biosyent's COGS to Revenue for the three months ended in Dec. 2023 was 0.19.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Biosyent's Gross Margin % for the three months ended in Dec. 2023 was 81.04%.

Biosyent COGS-to-Revenue Historical Data

The historical data trend for Biosyent's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biosyent COGS-to-Revenue Chart

Biosyent Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.22

0.21

0.18

0.19

Biosyent Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															0.17	0.18	0.18	0.20	0.19

Biosyent COGS-to-Revenue Calculation

Biosyent's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	4.467	/	23.547
	=	0.19

Biosyent's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	1.169	/	6.167
	=	0.19

Biosyent (OTCPK:BIOYF) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Biosyent's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	1.169 / 6.167
	=	81.04 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Biosyent COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Biosyent's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Biosyent (Biosyent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biosyent Inc (OTCPK:BIOYF) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

RX:Canada

Address

2476 Argentia Road, Suite 402, Toronto, Mississauga, ON, CAN, L5N 6M1

Website

http://www.biosyent.com

Biosyent Inc is a Canada-based growth-oriented specialty pharmaceutical company. It has focused on in-licensing or acquiring originative pharmaceuticals and other healthcare products. Its product includes FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Repagyn, and Tibella.